160 related articles for article (PubMed ID: 18007584)
1. Cidofovir diphosphate inhibits molluscum contagiosum virus DNA polymerase activity.
Watanabe T; Tamaki K
J Invest Dermatol; 2008 May; 128(5):1327-9. PubMed ID: 18007584
[No Abstract] [Full Text] [Related]
2. Cidofovir for the Treatment of Molluscum Contagiosum Virus.
De Clercq E
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366582
[TBL] [Abstract][Full Text] [Related]
3. Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.
Florescu DF; Keck MA
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1171-8. PubMed ID: 25120093
[TBL] [Abstract][Full Text] [Related]
4. Topical cidofovir for severe molluscum contagiosum.
Davies EG; Thrasher A; Lacey K; Harper J
Lancet; 1999 Jun; 353(9169):2042. PubMed ID: 10376628
[No Abstract] [Full Text] [Related]
5. Topical cidofovir for molluscum contagiosum in children.
Zabawski EJ; Cockerell CJ
Pediatr Dermatol; 1999; 16(5):414-5. PubMed ID: 10627225
[No Abstract] [Full Text] [Related]
6. Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient.
Ibarra V; Blanco JR; Oteo JA; Rosel L
Acta Derm Venereol; 2000; 80(4):315-6. PubMed ID: 11028878
[No Abstract] [Full Text] [Related]
7. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate.
Magee WC; Hostetler KY; Evans DH
Antimicrob Agents Chemother; 2005 Aug; 49(8):3153-62. PubMed ID: 16048917
[TBL] [Abstract][Full Text] [Related]
8. Detection of molluscum contagiosum virus (MCV) DNA in the plasma of an immunocompromised patient and possible reduction of MCV DNA with CMX-001.
Cohen JI; Davila W; Ali MA; Turk SP; Cowen EW; Freeman AF; Wang K
J Infect Dis; 2012 Mar; 205(5):794-7. PubMed ID: 22262788
[TBL] [Abstract][Full Text] [Related]
9. Topical cidofovir and cryotherapy--combination treatment for recalcitrant molluscum contagiosum in a patient with HIV infection.
Baxter KF; Highet AS
J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):230-1. PubMed ID: 15009318
[No Abstract] [Full Text] [Related]
10. [Efficacy and safety of intravenous cidofovir in the treatment of giant molluscum contagiosum in an immunosuppressed patient].
Foissac M; Goehringer F; Ranaivo IM; May T; Cuny JF; Schmutz JL; Lekaditi M
Ann Dermatol Venereol; 2014 Oct; 141(10):620-2. PubMed ID: 25288067
[No Abstract] [Full Text] [Related]
11. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.
Toro JR; Wood LV; Patel NK; Turner ML
Arch Dermatol; 2000 Aug; 136(8):983-5. PubMed ID: 10926733
[No Abstract] [Full Text] [Related]
12. Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir.
Hicks LD; Duvic M
Int J Dermatol; 2008 Dec; 47(12):1304-5. PubMed ID: 19126022
[No Abstract] [Full Text] [Related]
13. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir.
Meadows KP; Tyring SK; Pavia AT; Rallis TM
Arch Dermatol; 1997 Aug; 133(8):987-90. PubMed ID: 9267245
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravenous cidofovir in the treatment of giant molluscum contagiosum in a patient with human immunodeficiency virus.
Erickson C; Driscoll M; Gaspari A
Arch Dermatol; 2011 Jun; 147(6):652-4. PubMed ID: 21339417
[No Abstract] [Full Text] [Related]
15. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
Chamberlain JM; Sortino K; Sethna P; Bae A; Lanier R; Bambara RA; Dewhurst S
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397065
[TBL] [Abstract][Full Text] [Related]
16. Detection of Molluscum contagiosum virus (MCV) subtype I as a single dominant virus subtype in Molluscum lesions from a Turkish population.
Saral Y; Kalkan A; Ozdarendeli A; Bulut Y; Doymaz MZ
Arch Med Res; 2006 Apr; 37(3):388-91. PubMed ID: 16513490
[TBL] [Abstract][Full Text] [Related]
17. 1% topical cidofovir used as last alternative to treat viral infections.
Briand S; Milpied B; Navas D; Thomare P; Stalder JF
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429
[No Abstract] [Full Text] [Related]
18. Topical evening primrose oil as a possible therapeutic alternative in children with molluscum contagiosum.
Kwon HS; Lee JH; Kim GM; Choi EH; Bae JM
Clin Exp Dermatol; 2017 Dec; 42(8):923-925. PubMed ID: 28940438
[No Abstract] [Full Text] [Related]
19. Potency of a small molecule that targets the molluscum contagiosum virus processivity factor increases when conjugated to a tripeptide.
Guan H; Nuth M; Scott RW; Parker MH; Strobel ED; Reitz AB; Kulp JL; Ricciardi RP
Antiviral Res; 2024 Jun; 226():105899. PubMed ID: 38705201
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of topical cidofovir treatment for recalcitrant molluscum contagiosum in immunocompromised children].
Guérin M; Lepêcheur V; Rachieru-Sourisseau P; Réguerre Y; Pellier I; Martin L
Arch Pediatr; 2012 Nov; 19(11):1157-63. PubMed ID: 23037586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
